NanoInk Raises $65M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced a $65 million financing led by Lurie Investments.

The Skokie, Ill., nanotechnology development and applications firm said in a statement that the money will be used to convert outstanding debt to equity and to expand its commercial activities. NanoInk markets and sells nine nanotechnology products across its different divisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.